2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid

CAS: 52214-84-3

Ref. 3D-FD11320

Product Information

• Name: 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
• Synonyms: Ciprofibrate, 2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid, 2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid, 2-[4-(2,2-Dichloro-cyclopropyl)-phenoxy]-2-methyl-propionic acid, Brn 1984981, Ccris 173, Ciprofibrato, Ciprofibrato [INN-Spanish], Ciprofibratum, Ciprofibratum [INN-Latin], Ciprol, Lipanor, Modalim, Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-, Unii-F8252Jgo9S, Win 35833

Description

2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid (CGP) is a drug that blocks the nuclear receptor PPARγ. It has been shown to reduce cholesterol levels by inhibiting the synthesis of cholesterol, as well as reducing liver lesions in vivo. CGP also inhibits the growth of cancer cells through its ability to bind to DNA and regulate transcriptional activity. The response element for this compound is found in the promoter region of the gene encoding the growth factor-β1 (GF-β1), which is an important regulator of cell proliferation, differentiation, and apoptosis. CGP also inhibits peroxisome proliferator activator receptor α (PPARα) and γ (PPARγ). This inhibition leads to decreased expression of genes involved in lipid metabolism, such as acyl CoA synthase and fatty acid synthetase. CGP has also been shown to be carcinogenic in vivo

• Brand: Biosynth

Chemical properties

• Molecular weight: 289.15 g/mol
• Formula: C₁₃H₁₄Cl₂O₃
• Purity: Min. 98 Area-%
• Color/Form: Powder
• InChI: InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)
• InChI key: InChIKey=KPSRODZRAIWAKH-UHFFFAOYSA-N
• SMILES: CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O